<p>根據 AlphaQuest LLC 在最近向證券交易委員會提交的 13F 表格，該公司在第一季度將其在強生（NYSE:JNJ - 免費報告）的持股增加了 26.8%。在該季度購買了額外的 2,818 股後，該機構投資者持有該公司 13,338 股股票。根據其最近的 SEC 文件，AlphaQuest LLC 在強生的持股價值為 2,212,000 美元。</p>
<ul>
<li>JNJ 股票上漲表明對新增長路徑的信心</li>
</ul>
<p>其他機構投資者和對沖基金也買賣了該公司的股票。Highline Wealth Partners LLC 在第一季度將其在強生的股份增加了 51.8%。Highline Wealth Partners LLC 現在擁有 252 股該公司的股票，價值 42,000 美元，此前在上個季度購買了 86 股。Stone House Investment Management LLC 在第一季度獲得了強生的新頭寸，價值 47,000 美元。von Borstel &amp; Associates Inc.在第一季度獲得了強生的新頭寸，價值 49,000 美元。Capital A Wealth Management LLC 在第四季度獲得了強生的新頭寸，價值 50,000 美元。最後，Harvest Fund Management Co. Ltd 在第一季度獲得了強生的新頭寸，價值 52,000 美元。機構投資者持有該公司 69.55% 的股票。</p>
<p>獲取 <strong>強生</strong> 的提醒：</p>
<h2>華爾街分析師預測增長</h2>
<p>一些股票分析師最近對該股票發表了看法。摩根士丹利將強生股票的目標價格從 171.00 美元上調至 176.00 美元，並在 7 月 17 日的報告中給予該股票 “持平” 評級。Benchmark 在 4 月 24 日的報告中將強生股票升級為 “強力買入” 評級。Piper Sandler 在 7 月 17 日的報告中重申了對強生股票的 “增持” 評級。花旗將強生股票的目標價格從 185.00 美元上調至 200.00 美元，並在週四給予該公司 “買入” 評級。最後，巴克萊在 7 月 17 日的研究報告中將強生股票的目標價格從 165.00 美元上調至 176.00 美元，並給予該公司 “持平” 評級。兩位投資分析師對該股票給予了 “強力買入” 評級，九位給予了 “買入” 評級，九位對該公司給予了 “持有” 評級。根據 MarketBeat 的數據，該公司的共識評級為 “適度買入”，平均目標價格為 176.29 美元。</p>
<ul>
<li>3 只強勁盈利的高分紅股票</li>
</ul>
<p><strong>查看我們關於 JNJ 的最新報告</strong></p>
<h2>強生股票上漲 0.0%</h2>
<p>強生股票在週五開盤價為 178.8990 美元。強生的 52 周低點為 140.68 美元，52 周高點為 180.61 美元。該公司的 50 日簡單移動平均線為 163.04 美元，200 日簡單移動平均線為 159.05 美元。該公司的債務與股本比率為 0.50，速動比率為 0.76，流動比率為 1.01。該公司的市值為 4308.5 億美元，市盈率為 19.13，市盈增長比率為 2.28，貝塔值為 0.41。</p>
<ul>
<li>擔心反彈消退？考慮這 3 只高分紅股票</li>
</ul>
<p>強生（NYSE:JNJ - 獲取免費報告）最近在 7 月 16 日發佈了季度財報。該公司報告每股收益為 2.77 美元，超出市場共識預期的 2.68 美元，超出 0.09 美元。該季度的營業收入為 237.4 億美元，而分析師預期為 228.5 億美元。強生的淨利潤率為 25.00%，股本回報率為 32.49%。強生的收入同比增長 5.8%。在去年同期，該公司每股收益為 2.82 美元。強生已將其 2025 財年的指導目標設定為 10.800-10.900 每股收益。作為一個整體，賣方分析師預計強生在當前年度的每股收益為 10.58 美元。</p>
<h2>強生股息公告</h2>
<p>該公司最近還宣佈了一項季度股息，將於 9 月 9 日（星期二）支付。8 月 26 日（星期二）的股東將獲得 1.30 美元的股息。該股息的除息日期為 8 月 26 日（星期二）。這相當於每年 5.20 美元的股息，股息收益率為 2.9%。強生的股息支付比率為 55.61%。</p>
<h2>強生公司簡介</h2>
<p>（免費報告）</p>
<p>強生是一家控股公司，專注於醫療保健領域的產品研究、開發、製造和銷售。它通過創新藥物和醫療技術兩個部門運營。創新藥物部門專注於免疫學、傳染病、神經科學、腫瘤學、心血管和代謝以及肺動脈高壓。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票比強生更好</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>小型股，大潛力：您應該瞭解的 3 家科技顛覆者</li>
<li>股票中的缺口上漲意味着什麼？如何利用缺口</li>
<li>在盈利未達預期後，沃爾瑪仍然是頂級消費品股票</li>
<li>最佳能源股票 - 現在值得購買的能源股票</li>
</ul>
<p><strong>想看看其他對沖基金持有的 JNJ 嗎？</strong> 訪問 HoldingsChannel.com，獲取強生（NYSE:JNJ - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元在強生嗎？</h2>
<p>在您考慮強生之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而強生並不在名單上。</p>
<p>雖然強生目前在分析師中獲得了中性買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

強生

<p>AlphaQuest LLC 在第一季度將其在強生（NYSE: JNJ）的持股增加了 26.8%，額外購買了 2,818 股，總持股達到 13,338 股，價值 221 萬美元。其他機構投資者也增加了他們的持股。分析師對 JNJ 的共識評級為 “適度買入”，目標價格平均為 176.29 美元。該公司報告第二季度每股收益為 2.77 美元，超出預期，並宣佈季度股息為 1.30 美元，將於 9 月 9 日支付</p>

<p>AlphaQuest LLC lifted its holdings in Johnson &amp; Johnson (NYSE:JNJ - Free Report) by 26.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 13,338 shares of the company's stock after purchasing an additional 2,818 shares during the quarter. AlphaQuest LLC's holdings in Johnson &amp; Johnson were worth $2,212,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>根據 AlphaQuest LLC 在最近向證券交易委員會提交的 13F 表格，該公司在第一季度將其在強生（NYSE:JNJ - 免費報告）的持股增加了 26.8%。在該季度購買了額外的 2,818 股後，該機構投資者持有該公司 13,338 股股票。根據其最近的 SEC 文件，AlphaQuest LLC 在強生的持股價值為 2,212,000 美元。</p>
</div><ul>
<li>JNJ Stock Surge Signals Confidence in New Growth Path</li>
</ul>
<div class="lb-trans"><ul>
<li>JNJ 股票上漲表明對新增長路徑的信心</li>
</ul>
</div><p>Other institutional investors and hedge funds have also bought and sold shares of the company. Highline Wealth Partners LLC grew its stake in Johnson &amp; Johnson by 51.8% in the first quarter. Highline Wealth Partners LLC now owns 252 shares of the company's stock valued at $42,000 after purchasing an additional 86 shares in the last quarter. Stone House Investment Management LLC acquired a new position in Johnson &amp; Johnson during the first quarter worth $47,000. von Borstel &amp; Associates Inc. acquired a new position in Johnson &amp; Johnson during the first quarter worth $49,000. Capital A Wealth Management LLC acquired a new position in Johnson &amp; Johnson during the fourth quarter worth $50,000. Finally, Harvest Fund Management Co. Ltd acquired a new position in Johnson &amp; Johnson during the first quarter worth $52,000. Institutional investors own 69.55% of the company's stock.</p>
<div class="lb-trans"><p>其他機構投資者和對沖基金也買賣了該公司的股票。Highline Wealth Partners LLC 在第一季度將其在強生的股份增加了 51.8%。Highline Wealth Partners LLC 現在擁有 252 股該公司的股票，價值 42,000 美元，此前在上個季度購買了 86 股。Stone House Investment Management LLC 在第一季度獲得了強生的新頭寸，價值 47,000 美元。von Borstel &amp; Associates Inc.在第一季度獲得了強生的新頭寸，價值 49,000 美元。Capital A Wealth Management LLC 在第四季度獲得了強生的新頭寸，價值 50,000 美元。最後，Harvest Fund Management Co. Ltd 在第一季度獲得了強生的新頭寸，價值 52,000 美元。機構投資者持有該公司 69.55% 的股票。</p>
</div><p>Get <strong>Johnson &amp; Johnson</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>強生</strong> 的提醒：</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>A number of equities analysts recently weighed in on the stock. Morgan Stanley boosted their target price on shares of Johnson &amp; Johnson from $171.00 to $176.00 and gave the stock an &#34;equal weight&#34; rating in a report on Thursday, July 17th. Benchmark upgraded shares of Johnson &amp; Johnson to a &#34;strong-buy&#34; rating in a report on Thursday, April 24th. Piper Sandler reiterated an &#34;overweight&#34; rating on shares of Johnson &amp; Johnson in a report on Thursday, July 17th. Citigroup upped their price objective on shares of Johnson &amp; Johnson from $185.00 to $200.00 and gave the company a &#34;buy&#34; rating in a report on Thursday. Finally, Barclays upped their price target on shares of Johnson &amp; Johnson from $165.00 to $176.00 and gave the company an &#34;equal weight&#34; rating in a research note on Thursday, July 17th. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $176.29.</p>
<div class="lb-trans"><p>一些股票分析師最近對該股票發表了看法。摩根士丹利將強生股票的目標價格從 171.00 美元上調至 176.00 美元，並在 7 月 17 日的報告中給予該股票 “持平” 評級。Benchmark 在 4 月 24 日的報告中將強生股票升級為 “強力買入” 評級。Piper Sandler 在 7 月 17 日的報告中重申了對強生股票的 “增持” 評級。花旗將強生股票的目標價格從 185.00 美元上調至 200.00 美元，並在週四給予該公司 “買入” 評級。最後，巴克萊在 7 月 17 日的研究報告中將強生股票的目標價格從 165.00 美元上調至 176.00 美元，並給予該公司 “持平” 評級。兩位投資分析師對該股票給予了 “強力買入” 評級，九位給予了 “買入” 評級，九位對該公司給予了 “持有” 評級。根據 MarketBeat 的數據，該公司的共識評級為 “適度買入”，平均目標價格為 176.29 美元。</p>
</div><ul>
<li>3 Big Dividend Plays With Strong Earnings to Back Them</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只強勁盈利的高分紅股票</li>
</ul>
</div><p><strong>Check Out Our Latest Report on JNJ</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 JNJ 的最新報告</strong></p>
</div><h2>Johnson &amp; Johnson Trading Up 0.0%</h2>
<div class="lb-trans"><h2>強生股票上漲 0.0%</h2>
</div><p>JNJ stock opened at $178.8990 on Friday. Johnson &amp; Johnson has a 52 week low of $140.68 and a 52 week high of $180.61. The company's 50-day simple moving average is $163.04 and its 200 day simple moving average is $159.05. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.76 and a current ratio of 1.01. The company has a market capitalization of $430.85 billion, a PE ratio of 19.13, a price-to-earnings-growth ratio of 2.28 and a beta of 0.41.</p>
<div class="lb-trans"><p>強生股票在週五開盤價為 178.8990 美元。強生的 52 周低點為 140.68 美元，52 周高點為 180.61 美元。該公司的 50 日簡單移動平均線為 163.04 美元，200 日簡單移動平均線為 159.05 美元。該公司的債務與股本比率為 0.50，速動比率為 0.76，流動比率為 1.01。該公司的市值為 4308.5 億美元，市盈率為 19.13，市盈增長比率為 2.28，貝塔值為 0.41。</p>
</div><ul>
<li>Worried About a Fading Rally? Consider These 3 Dividend Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>擔心反彈消退？考慮這 3 只高分紅股票</li>
</ul>
</div><p>Johnson &amp; Johnson (NYSE:JNJ - Get Free Report) last posted its quarterly earnings data on Wednesday, July 16th. The company reported $2.77 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.09. The business had revenue of $23.74 billion during the quarter, compared to analysts' expectations of $22.85 billion. Johnson &amp; Johnson had a net margin of 25.00% and a return on equity of 32.49%. Johnson &amp; Johnson's revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.82 earnings per share. Johnson &amp; Johnson has set its FY 2025 guidance at 10.800-10.900 EPS. As a group, sell-side analysts anticipate that Johnson &amp; Johnson will post 10.58 earnings per share for the current year.</p>
<div class="lb-trans"><p>強生（NYSE:JNJ - 獲取免費報告）最近在 7 月 16 日發佈了季度財報。該公司報告每股收益為 2.77 美元，超出市場共識預期的 2.68 美元，超出 0.09 美元。該季度的營業收入為 237.4 億美元，而分析師預期為 228.5 億美元。強生的淨利潤率為 25.00%，股本回報率為 32.49%。強生的收入同比增長 5.8%。在去年同期，該公司每股收益為 2.82 美元。強生已將其 2025 財年的指導目標設定為 10.800-10.900 每股收益。作為一個整體，賣方分析師預計強生在當前年度的每股收益為 10.58 美元。</p>
</div><h2>Johnson &amp; Johnson Dividend Announcement</h2>
<div class="lb-trans"><h2>強生股息公告</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 26th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, August 26th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.9%. Johnson &amp; Johnson's dividend payout ratio is 55.61%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度股息，將於 9 月 9 日（星期二）支付。8 月 26 日（星期二）的股東將獲得 1.30 美元的股息。該股息的除息日期為 8 月 26 日（星期二）。這相當於每年 5.20 美元的股息，股息收益率為 2.9%。強生的股息支付比率為 55.61%。</p>
</div><h2>Johnson &amp; Johnson Company Profile</h2>
<div class="lb-trans"><h2>強生公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Johnson &amp; Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.</p>
<div class="lb-trans"><p>強生是一家控股公司，專注於醫療保健領域的產品研究、開發、製造和銷售。它通過創新藥物和醫療技術兩個部門運營。創新藥物部門專注於免疫學、傳染病、神經科學、腫瘤學、心血管和代謝以及肺動脈高壓。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Johnson &amp; Johnson</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>Small Cap, Big Potential: 3 Tech Disruptors You Should Know About</li>
<li>What Does a Gap Up Mean in Stocks? How to Play the Gap</li>
<li>After Earnings Miss, Walmart Is Still a Top Consumer Staples Play</li>
<li>Best Energy Stocks - Energy Stocks to Buy Now</li>
<li>How Cisco Is Building a New Growth Story for Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比強生更好</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>小型股，大潛力：您應該瞭解的 3 家科技顛覆者</li>
<li>股票中的缺口上漲意味着什麼？如何利用缺口</li>
<li>在盈利未達預期後，沃爾瑪仍然是頂級消費品股票</li>
<li>最佳能源股票 - 現在值得購買的能源股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding JNJ?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson &amp; Johnson (NYSE:JNJ - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 JNJ 嗎？</strong> 訪問 HoldingsChannel.com，獲取強生（NYSE:JNJ - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=JNJ"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Johnson &amp; Johnson Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元在強生嗎？</h2>
</div><p>Before you consider Johnson &amp; Johnson, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮強生之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson &amp; Johnson wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而強生並不在名單上。</p>
</div><p>While Johnson &amp; Johnson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然強生目前在分析師中獲得了中性買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

AlphaQuest LLC 收購了 2,818 股強生公司股票 $JNJ